B. Robinzon et al., OXYTOCIN ANTAGONIST BLOCKS THE VASODEPRESSOR BUT NOT THE VASOPRESSOR EFFECT OF NEUROHYPOPHYSEAL PEPTIDES IN CHICKENS, Peptides, 15(8), 1994, pp. 1407-1413
Cockerels with permanent cannulas in the brachial artery and vein were
put into isolated slings. Arterial pressure and heart rate were conti
nuously recorded. Following habituation, tests were initiated. In each
cockerel 2 nmol/kg of the tested neurohypophysial peptide (NPs) or an
alogue was IV injected six times at 6-min intervals. Arginine vasotoci
n (AVT) caused an immediate vasodepressor (VDP) effect and tachycardia
. These subsided within 20-30 s and were followed by a vasopressor (VP
) response and bradycardia. On repeated injections of AVT, the VDP res
ponse declined and bradycardia intensified. Arginine vasopressin (AVP)
, oxytocin (OT), and mesotocin (MT) had short-lasting VDP effect in th
e following order of potency: OT = MT > AVT > AVP. Only AVT and, more
effectively, AVP, caused a VP response. The VDP effect of MT and OT de
clined on repeated injections. When AVT was injected after three injec
tions of MT, it had mostly an immediate VP effect. Although the V-1 ag
onist is VP in chickens, at the dose used the V-1 antagonist, [d(CH2)(
5),O-Me-Tyr(2)]AVP, had no effect on cardiovascular responses to AVT.
Pretreatment with OT antagonist, [d(CH2)(5)-O-Me-Tyr(2,)Thr(4,)Tyr(9,)
Orn(8)]VT, abolished the VDP effect of all NPs. Thus, MT had no effect
on blood pressure, whereas AVP and, more effectively, AVT, had a mark
ed immediate VP action. In chickens the VDP effect of NPs is probably
mediated by an OT/MT-like receptor, wherein the peptide's ring structu
re, shared by AVT, OT, and MT, is important. The VP effect is mediated
by a receptor only partially similar to the mammalian V-1 receptor, w
here arginine in position 8, shared only by AVT and AVP, is necessary
for action, and the native AVT is more effective than the mammalian AV
P. This receptor reacts to the V-1 agonist but probably not to the V-1
antagonist.